Gene Therapy Market Quantitative Analysis, Current and Future Trends

1. Healthcare © P&S Intelligence. All rights reserved Page 1

2. Global Gene Therapy Market to Exhibit Over 30.0% CAGR Between 2020 and 2030 The global gene therapy market was valued at $3,407.5 million in 2019. According to the forecast of P&S Intelligence, a market research company based in India, the market will advance at a CAGR of 31.1% between 2020 and 2030. The positive results of various clinical trials, the increasing prevalence of chronic diseases, and the soaring R&D (research and development) activities being conducted in gene therapy are the main factors fueling the advancement of the market. The rising prevalence of chronic diseases such as cancer and many rare diseases is a major growth driver of the gene therapy market. This is because the gene therapies, that are currently available to healthcare professionals, have the ability to treat various rare diseases, especially the ones that have genetic causes. For example, cancer therapies do not require long-term transgene expression. There has been a sharp rise in cancer cases throughout the world in recent times. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/gene- therapy-market/report-sample Between them, the in vivo category is predicted to register higher growth in the market in the future years. This would be because unlike the ex vivo method, the in vivo approach eliminates the need for removing the cells from the patient’s body, manipulating the cells after removing them, and returning the cells to the body. In addition to this, in the in vivo approach, the host cells are not harmed and as a result, their functioning is not disrupted. Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry- url=gene-therapy-market Based on application, the gene therapy market is classified into oncology, rare diseases, neurology, ophthalmology, hematology, cardiology, and infectious diseases. Out of these, the oncology category generated the highest revenue in the market in 2019, mainly because of the high incidence of cancer all over the globe and the fact that nearly 60% of all the currently ongoing gene therapy clinical trials are targeted at cancer therapy. This is because gene therapy exhibits high selectivity in killing tumor cells. Across the globe, the gene therapy market is predicted to register the fastest progress in the Asia-Pacific (APAC) region in the upcoming years. The presence of cost-effective labor, the rising operations of prominent market players, and the emergence of several group investors are the main factors fueling the expansion of the market in this region. In addition to this, the APAC nations are increasingly enacting regulations and policies for regulating the production and approval procedures of various gene therapy products. © P&S Intelligence. All rights reserved Page 2

3. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 © P&S Intelligence. All rights reserved Page 3